Loading...

medmix AG

MEDX.SW•SIX
Industrials
Industrial - Machinery
CHF12.94
CHF-0.06(-0.46%)

medmix AG (MEDX.SW) Stock Overview

Explore medmix AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap527.8M
P/E Ratio-71.33
EPS (TTM)$-0.18
ROE-0.02%
Fundamental Analysis

AI Price Forecasts

1 Week$10.39
1 Month$8.19
3 Months$9.22
1 Year Target$7.49

MEDX.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of medmix AG (MEDX.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -71.33 and a market capitalization of 527.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

66.94RSI (14)
0.53MACD
29.78ADX
Revenue Growth
-0.55%
↓ 0.55%
Profit Growth
CHF-0.18
↓ 2566.67%
EPS Growth
CHF-0.18
↓ 2428.77%
Operating Margin
3.64%
↓ 19.38%
ROE
-1.65%
↓ 2566.67%
Dividend Yield
0.00%
↓ 5.69%
Analyst Recommendations data is not available for MEDX.SWAnalyst Recommendations details for MEDX.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.

CEO

Jennifer Dean

Employees

2,684

Headquarters

Dammstrasse 19, Zug

Founded

2021

Frequently Asked Questions

;